Wassim W Labaki
Assistant Professor of Internal Medicine

Available to mentor

Wassim W Labaki
Assistant Professor
  • About
  • Qualifications
  • Recent Publications
  • About

    Dr. Labaki is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at the University of Michigan. He received his medical degree from Georgetown University. He then completed a residency in internal medicine at Johns Hopkins and a fellowship in pulmonary and critical care medicine at the University of Michigan where he also earned a master’s degree in Clinical Research Design and Statistical Analysis.

    Dr. Labaki is a provider in the COPD Clinic, the medical director of the Lung Volume Reduction Program and co-chair of the COPD Quality Improvement Committee at the University of Michigan. He conducts clinical and translational research in COPD with a focus on chest imaging biomarkers and metabolomics. He has also been a principal investigator or co-investigator in several NIH and industry-sponsored COPD studies and clinical trials. In 2019, he received the Sreedhar Nair Early-Stage Investigator Award in COPD from the American Thoracic Society.

    Qualifications
    • MS
      University of Michigan, Ann Arbor, MI, 2019
    • MD
      Georgetown University School of Medicine, 3900 Reservoir Road NW Med-Dent Building, Annex 5, Box 571418, 2012
    Recent Publications See All Publications
    • Journal Article
      Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
      Bell AJ, Pal R, Labaki WW, Hoff BA, Wang JM, Murray S, Kazerooni EA, Galban S, Lynch DA, Humphries SM, Martinez FJ, Hatt CR, Han MK, Ram S, Galban CJ. Respir Res, 2024 Feb 28; 25 (1): 106 DOI:10.1186/s12931-024-02729-x
      PMID: 38419014
    • Journal Article
      Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
      Zhang WZ, Rice MC, Hoffman KL, Oromendia C, Barjaktarevic IZ, Wells JM, Hastie AT, Labaki WW, Cooper CB, Comellas AP, Criner GJ, Krishnan JA, Paine R, Hansel NN, Bowler RP, Barr RG, Peters SP, Woodruff PG, Curtis JL, Han MK, Ballman KV, Martinez FJ, Choi AM, Nakahira K, Cloonan SM, Choi ME, SPIROMICS Investigators . JCI Insight, 2024 Jun 24; 9 (12): DOI:10.1172/jci.insight.181925
      PMID: 38912587
    • Journal Article
      Leveraging CT Imaging to Detect COPD and Concomitant Chronic Diseases.
      Labaki WW, Agusti A, Bhatt SP, Bodduluri S, Criner GJ, Fabbri LM, Halpin DMG, Lynch DA, Mannino DM, Miravitlles M, Papi A, Sin DD, Washko GR, Kazerooni EA, Han MK. Am J Respir Crit Care Med, 2024 Jun 6; DOI:10.1164/rccm.202402-0407PP
      PMID: 38843079
    • Presentation
      COPD clinical year in review
      2024 May;
    • Presentation
      GOLD 2024: what is new?
      2024 May;
    • Presentation
      Poster discussion session on "Emerging treatments and therapeutic strategies in COPD"
      2024 May;
    • Journal Article
      Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
      Ferrera MC, Lopez CL, Murray S, Jain RG, Labaki WW, Make BJ, Han MK. Ann Am Thorac Soc, 2024 Mar; 21 (3): 421 - 427. DOI:10.1513/AnnalsATS.202209-751OC
      PMID: 37796613
    • Presentation
      Small airways disease in COPD: noise in the "silent zone"
      2024 Mar;